Pfizer Pakistan products and prices in Pakistan
Importer / marketer Its products are registered under a DRAP Drug Sale Licence (DSL), typically imported finished products. Source: DRAP.
Follow price changes 🔒 Company report (Pharma Pro)Pharmaceutical company - Pfizer subsidiary · Karachi · Pakistan
Pakistan operating company of Pfizer, active in medicines and vaccines across multiple therapeutic areas since 1959.
Pfizer Pakistan products in Pakistan
Pfizer Pakistan Limited has 55 medicine presentations registered in Pakistan under 29 brands, covering 26 generic medicines. Most of its products are in Oncology & immunology, Anti-infectives and Reproductive & genitourinary. Its brands with the most registered strengths and packs are Dalacin C (Clindamycin), Zithromax (Azithromycin), Solu-Cortef (Hydrocortisone) and Adriblastina (Doxorubicin). 55 products have an official DRAP price on MedInfoBase. See all 29 brands A to Z
What is sourced, and how recent is it?
Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.
Company profile
- Company type
- Pharmaceutical company - Pfizer subsidiary
- Address
- 24th Floor, Sky Tower East Wing, Dolmen City, HC-3 Block 4, Scheme 5, Clifton, Karachi 75600, Pakistan · 75600
- Website
- pfizer.com.pk ↗
- Official contact
- Contact page ↗
- Corporate source details checked
- 16 Aug 2026
- Corporate profile completeness
- 75%
Company location
A sourced company location is recorded. Use the map link below for directions.
Portfolio at a glance
RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.
PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.
IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.
Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.
Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.
Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.
How complete is this profile?
Downloadable company intelligence charts
Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.
Therapeutic Portfolio Mix
Shows where the company portfolio is concentrated across broad therapeutic areas.
Portfolio distribution, not sales or market-share data.
Dosage Form Portfolio
Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.
Counts are product presentations, not production or sales volumes.
Equivalent Price Position
Shows whether safely comparable products are below, near or above the peer median unit price.
This is price-position intelligence, not sales, demand or market-share data.
Closest Portfolio Competitors
Highlights other manufacturers with the greatest generic overlap with this company portfolio.
Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.
Therapeutic areas
High-level clinical areas represented by this company’s current MedInfoBase portfolio.
Drug classes
More specific classes derived from the canonical generic and preserved curated classifications.
Dosage forms
How MedInfoBase classifies the portfolio
MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.
Deepest brand families
Unit-price positioning vs equivalent products
See where Pfizer Pakistan Limited is priced against the market
30 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.
How MedInfoBase calculates price position
Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.
Portfolio overlap
Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.
🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock
Observed database signals
These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.
Medicine portfolio
This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.
| Brand | Generic | Strength | Form | Pack | Registration | Source-listed price | Unit price | Price position |
|---|---|---|---|---|---|---|---|---|
| Solu-Cortef | Hydrocortisone | 250 mg | Powder for solution for injection | 1's (Vial) | 000603 | PKR 409.45 | PKR 409.45/vial/unit | No comparator |
| Solu-Cortef | Hydrocortisone | 100 mg | Powder for solution for injection | 1's (Vial) | 000604 | PKR 234.75 | PKR 234.75/vial/unit | No comparator |
| Solu-Cortef | Hydrocortisone | 500 mg | Powder for solution for injection | 1's (Vial) | 008253 | PKR 919.88 | PKR 919.88/vial/unit | No comparator |
All 29 Pfizer Pakistan brands in Pakistan
- Adriblastina Doxorubicin · 10 mg injection, 50 mg injection
- Antmal Artemether + Lumefantrine · 20 mg + 120 mg tablet
- Anzatax Paclitaxel · 100 mg/16.7 mL infusion
- Campto Irinotecan · 100 mg infusion, 40 mg infusion
- Carpsol Carboplatin · 150 mg/15 mL injection
- Cisplasol Cisplatin · 10 mg/10 mL injection
- Cytosar Cytarabine · 100 mg injection, 500 mg injection
- Dalacin C Clindamycin · 150 mg capsule, 150 mg/mL injection, 300 mg capsule
- Dalacin T Clindamycin · 1% w/w (10 mg/g) lotion
- Dalacin Vaginal Cream Clindamycin · 2% w/w (20 mg/g) cream
- DBL Docetaxel Docetaxel · 20 mg/2 mL infusion, 80 mg/8 mL infusion
- DBL Gemcitabine Gemcitabine · 1 g/26.3 mL injection, 200 mg/5.3 mL injection
- Depo-Provera Medroxyprogesterone acetate · 150 mg injection
- Diflucan Fluconazole · 2 mg/mL infusion
- Eliquis s Apixaban · 2.5 mg tablet, 5 mg tablet
- Meronem Meropenem · 1 g injection, 500 mg injection
- Pfizer Bortezomib Bortezomib · 3.5 mg injection
- Pfiziflox Levofloxacin · 250 mg tablet, 500 mg tablet
- Relevole Omeprazole · 20 mg capsule, 40 mg capsule
- Ruxience Rituximab · 100 mg infusion, 500 mg infusion
- Savoxacin Ciprofloxacin · 250 mg tablet, 500 mg tablet
- Sayana Press Medroxyprogesterone acetate · 104 mg/0.65 mL injection
- Solu-Cortef Hydrocortisone · 100 mg injection, 250 mg injection, 500 mg injection
- Stresstabs 600 Ascorbic acid + Nicotinamide + Pantothenic acid + Zinc + Thiamine + Riboflavin + Pyridoxine + Copper + Vitamin E + Folic acid + Biotin + Cyanocobalamin · 600 mg + 100 mg + 25 mg + 23.9 mg + 20 mg + 10 mg + 5 mg + 3 mg + 30 IU + 400 mcg + 45 mcg + 12 mcg tablet
- Trazimera Trastuzumab · 150 mg injection, 440 mg/vial infusion
- Xalacom Latanoprost + Timolol · 0.05 mg/mL + 5 mg/mL drops
- Zavicefta Ceftazidime + Avibactam · 2 g + 0.5 g injection, 2 g + 0.5 g infusion
- Zirabev Bevacizumab · 100 mg/4 mL injection, 400 mg/16 mL (25 mg/mL) infusion
- Zithromax Azithromycin · 200 mg/5 mL suspension, 250 mg capsule, 250 mg tablet
Pfizer Pakistan: common questions
How many products does Pfizer Pakistan have in Pakistan?
Pfizer Pakistan Limited has 55 registered medicine presentations in Pakistan, sold under 29 brands and covering 26 generic medicines.
What are the main brands of Pfizer Pakistan?
By number of registered strengths and packs, its largest brands are Dalacin C (Clindamycin), Zithromax (Azithromycin), Solu-Cortef (Hydrocortisone), Adriblastina (Doxorubicin) and Campto (Irinotecan). This is not a sales ranking.
Which therapy areas does Pfizer Pakistan cover?
The most products are in Oncology & immunology (22), Anti-infectives (20), Reproductive & genitourinary (4), Dermatology (3) and Hematology & thrombosis (2).
Where can I see Pfizer Pakistan medicine prices?
Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.
MedInfoBase company-intelligence methodology
This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.
Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.
Cite this record
Manufacturer recordRecords change over time. Please cite the access date so readers can locate the version you used.